Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693665 · ClinicalTrials.gov registry record · NA
Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
A NA study of Cancer, sponsored by Maureen Lyon.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 4
- Study locations
NCT02693665: Completed NA study of Cancer, sponsored by Maureen Lyon.
NCT02693665 is a NA study of Cancer that has completed, run by Maureen Lyon. The registered enrollment target is 260 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02693665, a NA study of Cancer, has completed, sponsored by Maureen Lyon.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 4
- Study locations
Study Summary
To test the efficacy of FACE-TC on key outcomes, the investigators propose using an intent-to-treat, longitudinal, prospective, multi-site, randomized controlled trial (RCT) design. Adolescents with cancer, aged 14 up to 20 years, and their families (N=130 dyads; N=260 participants) will be recruited and randomized to FACE-TC or Treatment as Usual (TAU) control. Participants will complete standardized questionnaires at baseline and 3, 6, 12, and 18 months post-intervention. Our goal is to assess the extent to which FACE-TC helps adolescents and young adults with cancer and their families: (1) reach and maintain better congruence in treatment preferences over time; (2) improve their quality of life; and (3) document goals of care and advance directives earlier in the course of their potentially life limiting illness.
Primary Outcome
Statement of Treatment Preferences documented adolescents' goals of care and families' understanding. Situations were: (1) prolonged hospital stay with ongoing medical intervention and low chance of survival; (2) treatments extend life by no more than 2-3 months with side-effects; (3) physical impairment; and (4) mental impairment. Choices for the four situations were "to continue all treatments …", "to stop all efforts to keep me alive…", or "do not know." Responses for data analysis were recod
Conditions Studied
Interventions
- BEHAVIORAL FAmily CEntered Advance Care Planning for Teens with Cancer
Study Locations (4)
District of Columbia
- Children's National Medical Center - Washington D.C.
Minnesota
- University of Minnesota Masonic Children's Hospital - Minneapolis
Ohio
- Akron Children's Hospital - Akron
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2016-07-16 |
| Est. Completion | 2022-09-29 |
| Phase | NA |
What the finished NCT02693665 record still lists
NCT02693665 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which FAmily CEntered Advance Care Planning for Teens with Cancer is the first listed.
NCT02693665 reports a single indexed study location in District of Columbia, Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT02693665 about?
NCT02693665 is a clinical study titled "Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer". To test the efficacy of FACE-TC on key outcomes, the investigators propose using an intent-to-treat, longitudinal, prospective, multi-site, randomized controlled trial (RCT) design. Adolescents with cancer, aged 14 up to 20 years, and their families (N=130 dyads; N=260 participants) will be recruite...
What is the current status of trial NCT02693665?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2016-07-16. Estimated completion is 2022-09-29.
What conditions does trial NCT02693665 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT02693665?
The interventions under investigation include: FAmily CEntered Advance Care Planning for Teens with Cancer (BEHAVIORAL).
Who is sponsoring clinical trial NCT02693665?
This trial is sponsored by Maureen Lyon, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02693665 being conducted?
This trial has 4 study locations across District of Columbia, Minnesota, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02693665's enrollment target sits among peer trials
260 200th of 615 higher than 413 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI